Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,058 | -18,702 | -65,447 | -45,109 | -31,410 |
| Depreciation Amortization | 2,983 | 2,922 | 10,962 | 9,290 | 4,789 |
| Accounts receivable | 580 | -33 | -1,501 | -765 | -1,757 |
| Other Working Capital | 15,872 | 5,646 | -4,344 | -4,903 | -2,234 |
| Other Operating Activity | 5,874 | 2,481 | 15,358 | 8,463 | 7,919 |
| Operating Cash Flow | $-6,749 | $-7,686 | $-44,972 | $-33,024 | $-22,693 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,093 | -7,676 | -3,298 | -1,368 | -591 |
| Net Acquisitions | N/A | -30 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -85 | N/A | -236 | -179 | -141 |
| Other Investing Activity | -85 | 0 | -236 | -179 | -141 |
| Investing Cash Flow | $-14,178 | $-7,706 | $-3,534 | $-1,547 | $-732 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 45,102 | 15,102 | 15,102 |
| Debt Repayment | -24 | -12 | -28,604 | -5,038 | -3,025 |
| Common Stock Issued | 507 | 426 | 60,162 | 18,470 | 16,429 |
| Other Financing Activity | -5,234 | -2,835 | -17,778 | -11,500 | -9,207 |
| Financing Cash Flow | $-4,751 | $-2,421 | $58,882 | $17,034 | $19,299 |
| Beginning Cash Position | 43,174 | 43,174 | 32,798 | 32,798 | 32,798 |
| End Cash Position | 17,496 | 25,361 | 43,174 | 15,261 | 28,672 |
| Net Cash Flow | $-25,678 | $-17,813 | $10,376 | $-17,537 | $-4,126 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,749 | -7,686 | -44,972 | -33,024 | -22,693 |
| Capital Expenditure | -14,093 | -7,676 | -3,298 | -1,368 | -591 |
| Free Cash Flow | -20,842 | -15,362 | -48,270 | -34,392 | -23,284 |